When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.
Perls’ stain
bone marrow
heme synthesis
iron overload
ring sideroblasts
sideroblastic anemia
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
20 Jul 2022
20 Jul 2022
Historique:
received:
30
05
2022
revised:
08
07
2022
accepted:
16
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Ring sideroblasts are commonly seen in myelodysplastic neoplasms and are a key condition for identifying distinct entities of myelodysplastic neoplasms according to the WHO classification. However, the presence of ring sideroblasts is not exclusive to myelodysplastic neoplasms. Ring sideroblasts are as well either encountered in non-clonal secondary acquired disorders, such as exposure to toxic substances, drug/medicine, copper deficiency, zinc overload, lead poison, or hereditary sideroblastic anemias related to X-linked, autosomal, or mitochondrial mutations. This review article will discuss diseases associated with ring sideroblasts outside the context of myelodysplastic neoplasms. Knowledge of the differential diagnoses characterized by the presence of ring sideroblasts in bone marrow is essential to prevent any misdiagnosis, which leads to delayed diagnosis and subsequent management of patients that differ in the different forms of sideroblastic anemia.
Identifiants
pubmed: 35885655
pii: diagnostics12071752
doi: 10.3390/diagnostics12071752
pmc: PMC9320983
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Hematology. 2020 Dec;25(1):283-285
pubmed: 32657243
Blood. 2018 Mar 22;131(12):1389
pubmed: 29567759
Eur J Haematol. 2004 May;72(5):358-60
pubmed: 15059072
Curr Hematol Malig Rep. 2012 Dec;7(4):310-20
pubmed: 23015360
Am J Hematol. 2012 Mar;87(3):305
pubmed: 21818765
Leuk Res. 2011 Dec;35(12):1605-10
pubmed: 21596435
Acta Haematol. 2009;122(2-3):120-33
pubmed: 19907149
Am J Hematol. 2012 Apr;87(4):413-6
pubmed: 22120958
Am J Hematol. 2021 Jul 1;96(7):761-763
pubmed: 33861878
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):185-9
pubmed: 23587584
Nat Genet. 2009 Jun;41(6):651-3
pubmed: 19412178
Hematol Oncol Clin North Am. 2014 Aug;28(4):653-70, v
pubmed: 25064706
Rev Med Liege. 2019 Oct;74(10):527-534
pubmed: 31609556
Ann Biol Clin (Paris). 2021 Feb 1;79(1):69-74
pubmed: 33527906
Blood. 2013 Jul 4;122(1):112-23
pubmed: 23553769
Br J Haematol. 2020 Sep;190(6):809
pubmed: 32510577
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Gene. 2018 Aug 20;668:182-189
pubmed: 29787825
Transfusion. 2022 May;62(5):961-973
pubmed: 35452143
Glasgow Med J. 1947 Sep;28(9):237-79
pubmed: 20264857
Blood. 2019 Feb 28;133(9):1000
pubmed: 30819781
Leukemia. 2022 May;36(5):1432-1435
pubmed: 35220402
Blood. 2014 Mar 20;123(12):1784
pubmed: 24783257
Blood. 2019 Jan 3;133(1):59-69
pubmed: 30401706
Blood. 2022 Apr 21;139(16):2460-2470
pubmed: 34932791
Blood. 2017 May 11;129(19):2710
pubmed: 28495927
Blood. 2021 Mar 11;137(10):1269
pubmed: 33512433
Am J Hematol. 2021 Mar 1;96(3):379-394
pubmed: 33428785
J Clin Invest. 2020 Oct 1;130(10):5245-5256
pubmed: 32634119
Haematologica. 2011 Jun;96(6):789-92
pubmed: 21632840
Haematologica. 2014 Jun;99(6):973-83
pubmed: 24881043
Adv Hematol. 2013;2013:309637
pubmed: 24194760
Haematologica. 2013 Nov;98(11):e138-40
pubmed: 24186315
Pediatr Blood Cancer. 2017 May;64(5):
pubmed: 27808451
J Blood Med. 2020 Sep 25;11:305-318
pubmed: 33061728
Blood. 2015 Jul 9;126(2):233-41
pubmed: 25957392
Blood. 2019 Feb 21;133(8):883
pubmed: 30792227
Clin Case Rep. 2020 Mar 06;8(6):991-994
pubmed: 32577249
J Pediatr. 1979 Dec;95(6):976-84
pubmed: 501502
Leuk Res. 2022 Apr;115:106820
pubmed: 35279478
Blood. 2014 Oct 30;124(18):2867-71
pubmed: 25193871
Haematologica. 2008 Nov;93(11):1712-7
pubmed: 18838480